Dowling & Yahnke’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
Sell
-68,381
Closed -$294K 274
2016
Q2
$294K Hold
68,381
0.04% 238
2016
Q1
$385K Buy
+68,381
New +$385K 0.05% 210
2014
Q4
Sell
-5,160
Closed -$220K 266
2014
Q3
$220K Buy
+5,160
New +$220K 0.03% 241